Bapotulimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bapotulimab, covering 2024-05-28 to 2024-05-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1. [Phase 1]